Evidence map›Paper›PMID 31565212›Full record

ArticleParkinson's disease2019

Variants in the 3' End of SLC6A3 in Northwest Han Population with Parkinson's.

Peiye Chang, Yongwang Fu, Ping Zhao, Chunmei Wang, Mingfang Jiang, Rui Li, Yulin He

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Parkinson's disease, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 87% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Peiye ChangDepartment of Nuclear Medicine, Inner Mongolia Medical University Affiliated Hospital, Hohhot, China.ORCID https://orcid.org/0000-0001-6164-2531
Yongwang FuDepartment of Hyperbaric Oxygen Treatment, Inner Mongolia Autonomous Region People's Hospital, Hohhot, China.ORCID https://orcid.org/0000-0002-2172-3801
Ping ZhaoDepartment of Cardiology, Inner Mongolia Autonomous Region People's Hospital, Hohhot, China.ORCID https://orcid.org/0000-0003-3491-9739
Chunmei WangDepartment of Nuclear Medicine, Inner Mongolia Medical University Affiliated Hospital, Hohhot, China.ORCID https://orcid.org/0000-0002-6287-8084
Mingfang JiangDepartment of Neurology, Affiliated Hospital of Inner Mongolia Medical University, Hohhot, China.
Rui LiDepartment of Neurology, Bayannaoer City Hospital, Bayannaoer, China.
Yulin HeDepartment of Nuclear Medicine, Inner Mongolia Medical University Affiliated Hospital, Hohhot, China.ORCID https://orcid.org/0000-0002-0645-7760
Inner Mongolia Medical University · CNInner Mongolia People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Parkinson's disease (PD) is one of the most common neurodegenerative disorders in neurology. It is possible that multifactorial and genetic factors are related to its pathogenesis. Recently, there have been reports of SLC6A3 genetic variants leading to PD. However, the role of 3' end of SLC6A3 in PD is less studied in different ethnic groups. To explore the roles of 3' end of SLC6A3 in PD development, 17 SNP sites in 3' end of SLC6A3 were analyzed in 360 PD patients and 392 normal controls of Han population residing in northwest of China. The significant difference of gene type and allele frequencies between the PD and control groups was detected only in rs40184 (

Identifiers

PMID31565212
PMCPMC6745156
OpenAlexW2971781004

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.